The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
When (Not) to Stop a Clinical Trial for Benefit
Abstract
cancer screening strategies in low-resource settings: clinical benefits and cost effectiveness. JAMA. 2001;285:3107-3115. 25. Crum CP. The beginning of the end for cervical cancer? N Engl J Med. 2002; 347:1703-1705. 26. Skjeldstad FE, Koustsky L; for theMerck Phase III HPV Vaccine Steering Com-mittee (FUTURE II). Phase III trial of prophylactic quadrivalent HPV 6, 11, 16, 18 L1 virus-like particle (VLP) vaccine: prevention of cervical intraepithelial neoplasia (CIN) 2/3 including adeno- and squamous-cell carcinoma in situ (CIS). Presented
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D. (2001) · JAMA · doi:10.1001/jama.285.15.1987 · Cited by 2,545
Contradicted and Initially Stronger Effects in Highly Cited Clinical Research
Ioannidis, J. P. A. (2005) · JAMA · doi:10.1001/jama.294.2.218 · Cited by 1,465
Moher, D., Schulz, K. F., Altman, D. G., & for the CONSORT Group* (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-8-200104170-00011 · Cited by 1,426
When to stop a clinical trial.
Pocock, S. J. (1992) · BMJ · doi:10.1136/bmj.305.6847.235 · Cited by 255 · cited 1×
“The ethical dilemma is to safeguard the interests of patients randomized in the current trial while also protecting society from overzealous premature claims of treatment benefit.(11) For instance, if a trial is evaluating a treatment meant to be given long-term for conditions such as hypertension or chronic arthritis…”
BackgroundSelf-citationSydes, M. R., Altman, D. G., Babikera, A. B., Parmar, M. K., Spiegelhalter, D. J., & DAMOCLES group (2004) · Clinical Trials · doi:10.1191/1740774504cn003oa · Cited by 49
Cited by
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111
Self-citationGRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
Guyatt, G. H., Oxman, A. D., Vist, G., Kunz, R., Brozek, J., Alonso-Coello, P., Montori, V., Akl, E. A., Djulbegovic, B., & Falck-Ytter, Y. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.017 · Cited by 2,798
Colchicine in Patients with Chronic Coronary Disease
Nidorf, S. M., Fiolet, A. T. L., Mosterd, A., Eikelboom, J. W., Schut, A., Opstal, T. S. J., The, S. H. K., Xu, X.-F., Ireland, M. A., Lenderink, T., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021372 · Cited by 2,299
Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis
Mas, J.-L., Chatellier, G., Beyssen, B., Branchereau, A., Moulin, T., Becquemin, J.-P., Larrue, V., Lièvre, M., Leys, D., Bonneville, J.-F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061752 · Cited by 1,578
Bassler, D. (2010) · JAMA · doi:10.1001/jama.2010.310 · Cited by 611
Metadata
- Authors
- Pocock, S. J.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2005-11-02
- Volume
- 294
- Issue
- 17
- Pages
- 2228
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2053830943
- Cited by
- 163
- References
- 5
- FWCI
- 10.30
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: When (Not) to Stop a Clinical Trial for Benefit. https://app.cochat.ai/papers/10.1001/jama.294.17.2228
- The paper
- Pocock, S. J. (2005). When (Not) to Stop a Clinical Trial for Benefit. JAMA. https://doi.org/10.1001/jama.294.17.2228
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.